| Logo | Name | Σ | Employees |
|---|---|---|---|
 |  pymetrics (now Harver) pymetrics is now Harver. Harver is the industry leading hiring solution helping organizations optimize their talent decisions. Rooted in over 35 years of rich data insights backed by I/O psychology and cognitive science, Harver delivers a suite of automated solutions that enables organizations to engage, hire, and develop the right talent in a fast and fundamentally less biased way. Having processed over 100 million candidates, Harver provides trusted, data-driven, and adaptable offerings, including assessments, video interviews, scheduling, and reference checking. Harver has helped more than 1,300 customers, including Booking.com, Peloton, Valvoline, and McDonald’s, take the smart path to the right … Type: | 20 | 24 |
 | Prellis Biologics Integrating human biology with machine learning for antibody discovery Prellis Bio is hiring Immunologists! We are expanding our Externalized Immune System, EXISTM, platform with applications in antibody discovery, immunogenicity, and vaccine screening all in the same platform. Prellis Biologics, Inc. is a privately held company based in the San Francisco Bay Area, CA. Apply at www.prellisbio.com. Lymph Node Organoids, Immunogenicity Screening, Human Antibody Discovery, and Antibody Discovery Type: | 11 | 49 |
 | Pivot Bio One of the world's leading innovative agtech companies, delivering farmers patented crop nutrition technologies. Pivot Bio is one of the world's leading innovative agtech companies, delivering farmers patented crop nutrition technologies. Type: | 11 | 376 |
 | PharmaBiome AG Pioneering the development of microbiome-based therapies using proprietary tools for their design and production. PharmaBiome is a privately-held spin-off company of ETH Zurich and a pioneer in the production of live biotherapeutic products to address disturbances of the gut microbiome. It has developed the first-in-the-industry, patent-protected technology platform for the production of standardized microbiome-based products. Founded in Zurich in 2015, at the intersection of microbiology, biotechnology, and data science, PharmaBiome believes that the future of microbiome-based therapeutics lies in developing the biotechnology needed to produce a solution compatible with the safety, efficiency, and trial requirements of any human medicine. This … Type: | 1 | 11 |
 |  Activatec Ltd Technology development, R&D, Biobased ingredients Activatec develops technologies to produce biobased ingredients from renewable sources. We are specialised in the evaluation, scale-up and commercialisation of processes to produce biotechnological and plant-based ingredients and materials from currently unused and low-value organic sources. Activatec is a B2B Partner that provides support to the industrial biotechnology sector in the form of research services on a contract basis. We are currently working within a number of international partner projects to design, develop and scale-up novel technologies for the production of emerging and high-value bio-based products. biotechnology, research and development, biotech, biobased products, bioproducts, bioingredients, … Type: | 3 | 1 |
 |  Enifer The brewers of PEKILO, the original mycoprotein. Sustainable protein is ready for scale! We are upcycling food industry by-products into planet-friendly protein, and pioneering a new approach to food systems—one that supports healthy, delicious diets for everyone while minimizing environmental impact. Enifer, a spin-off company from VTT Technical Research Centre of Finland, was founded by five scientists in 2020 to develop and commercialize the proprietary PEKILO® technology further. A process originally developed and used by the Finnish forest industry at a commercial scale, the PEKILO® technology enables the biotechnological conversion of dilute side streams into a high-protein and fiber ingredient, … Type: | 4 | 30 |
 | Lindus Health We are an anti-CRO running end-to-end clinical trials for life science pioneers. Lindus Health is an anti-CRO running radically faster, more reliable clinical trials for life science pioneers. We do this thanks to a commercial model that aligns incentives (fixed-price quotes per study, with milestone-based payments), marrying a world-class clinical operations team with our unique software platform, and access to 30 million Electronic Health Records. We handle the end-to-end execution of clinical studies, including design, patient recruitment, clinical data capture, monitoring and project management. We have helped over 40 sponsors run entire clinical studies across the US, UK, and Europe … Type: | 9 | 117 |
 | Hilltop Leaf Ltd Plant based medicine Hilltop Leaf Ltd is a U.K. plant based Medicine Company | 1 | 10 |
 | Mitra bio Unlocking the secrets of skin aging with epigenetics Next Generation Skin Health Type: | 3 | 8 |
 | Orano Med Innovative targeted alpha therapy to fight cancer using lead-212 (Pb-212) Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information … Type: | 13 | 162 |
 | OpenCell HIRING! Biotech makes the world a better place to live, so we’re making labs that are a better place to work. With so much potential for biotech to make the world a better place to live, we knew we needed to make the lab a better place to work. We’re a team of scientists and designers who have meticulously studied the in-lab experience, getting a detailed understanding of workflows and identifying common pain points that routinely cost scientists time and money. Our BioHotel labs are designed with biotech startups in mind: - Short term, flexible leases - Central London locations … | 5 | 8 |
 | Oncomfort Digital SedationTM is a drug-free therapy reducing patients' anxiety and pain during medical treatments and procedures. Oncomfort Digital SedationTM is a non-pharmacological therapy for relieving patients’ pain and anxiety before, during and after medical procedures. This digital therapy combines clinical hypnosis and integrative therapeutic techniques through Virtual Reality. Virtual Reality, Medical, Anxiety Management, Oncology, Pain Management, Radiology, eHealth, Digital Sedation, Sedation, and Clinical Hypnosis Type: | 12 | 3 |
 | Nuproxa Group of Companies Smart nutrition, naturally! High quality solutions for the animal nutrition and health industry. Nuproxa is a Swiss company founded in 2007, supplying high-quality solutions to the Animal Nutrition and Health Industry. Our solutions are 100% based on nature! With technology created by nature, unquestionably safe. Effective, with results demonstrated by scientific experiments and field tests in real conditions. Applicable to efficiently solve real problems faced by the ANH industry. Vision Nuproxa aims to contribute to a world where the well-being and nutrition of animals is provided by nature-based ingredients. Our commitment is to be the preferred supplier of natural solutions … Type: | 2 | 57 |
 | LimFlow Providing minimally-invasive options for the treatment of end-stage chronic limb-threatening ischemia (CLTI) LimFlow SA, part of Inari Medical, Inc., is a leading provider of medical technology that provides new hope to patients suffering from the most severe form of peripheral artery disease, Chronic Limb-Threatening Ischemia (CLTI), and who are facing the prospect of amputation. LimFlow is revolutionizing healthcare by offering a breakthrough solution for end-stage CLTI patients when traditional treatments fall short. Using an innovative percutaneous procedure, the LimFlow System reinvents anatomy to restore blood flow to the ischemic foot, which aims to alleviate pain, foster wound healing, reduce amputations … Type: | 1 | 25 |
 | Migraine Again Digital content company publishing daily news, tips and stories on ending migraine pain to help 500 million patients worldwide. We're leveraging the power of digital media (web, social, video) to radically improve lives of migraine sufferers - and others with chronic health problems for which there is no cure. Our mission is to help patients access unbiased, world-class insights and solutions to suffer less, live and work more – until there’s a cure. We empower patients with community and information they're not getting locally - effectively democratizing access to the world's top medical providers and cutting edge research. Better quality … Type: | 1 | 12 |
 | JooMo Ltd. Get your DREAM SKIN: Young, Clear & Radiant Skin using the power of the Skin Microbiome! We are the World's First 100% Truly Natural Face Wash. Our products are all free from preservatives, chemicals, and 'naturally derived' ingredients. Our Company is based on years of research and scientific studies we have conducted with ground breaking results. Our formulations get the skin to HEAL itself by increasing the biodiversity of your skin's microbiome! We are a small company created in 2010 by a small British family, who simply wanted better products to heal their skin problems. We care about our customers … Type: | 0 | 6 |
 | IT Cosmetics Discover IT. Love IT. Believe IT. Innovative Technology is IT. Developed with leading plastic surgeons, IT Cosmetics creates clinically-proven, innovative problem-solving makeup and skin care products that harness cutting edge, anti-aging technologies and high-performance, skin-loving ingredients to provide you with serious beauty solutions that help you look and feel your most beautiful! Our mission is to empower you through confidence in your skin, your makeup and your own beauty. IT’s your beauty, but better! Makeup, Cosmetics, Beauty, and Technology | 5 | 552 |
 | SAS IMPROVE IMPROVE an alternative protein CDMO Located in Dury near Amiens, The SAS IMPROVE is The Protein Innovation Center fully dedicated to alternative source of proteins. We produce and study nutritious and functionnal protein ingredients for food, feed and cosmetic applications. IMPROVE provide a high level of expertise from fundamental research to market knowledge. Industrial experience, scientific expertise, chemists and biochemists, process ingeneers...With a 800m2 pilot plant and 170m2 of laboratories IMPROVE offers a unique combination of skills and equipment to boost innovation and value generation for: Reducing time to market for new proteins products Enabling breakthrough innovations that meet market’s … Type: | 12 | 32 |
 | Verso Energy Build a decarbon and competitive energy mix comprising a high proportion of renewable energies Verso Energy specializes in the development, engineering, financing, construction and operation of pilotable renewable energy production installations, electricity storage facilities for the provision of electrical networks, and hydrogen decarbonated and synthetic molecules production facilities (e-methanol, E-SAF). Hydrogen, renewables, e-Molecules, Power-to-X, Flexibility, Battery Storage, Power, Decarbonation, CO2 Capture, and Project Development Type: | 24 | 66 |
 | Nexbiome Therapeutics Become the next champion in microbiome therapeutics Nexbiome therapeutics: The first private incubator of microbiome biotech companies Type: | 4 | 7 |
 | ONCOVITA Unleashing nature's own power to destroy cancer ONCOVITA is a biotechnology company based out of 28 RUE DU DOCTEUR ROUX, PARIS, France. Type: | 3 | 9 |
 | Omini Personalized multiplex blood testing platform to monitor chronic diseases Founded in 2019, Omini is developing the first point-of-care blood biomarker monitoring platform to transform the lives of patients suffering from chronic diseases, using its unique multiplex electrochemical biosensor technology. Multiplexing provides personalized blood biomarker data that can be used to adjust therapies and prevent acute crises in patients with chronic conditions. The affordable device combines a portable reader and single-use test strips, similar to a glucometer, simultaneously measuring four to ten blood biomarkers from a single capillary blood sample. It can be used at home or in outpatient care facilities … Type: | 8 | 49 |
 | Neurophoenix Unlocking neuron repair Neurophoenix is a preclinical stage biotech company advancing its rabies virus biomimicry based PTEN inactivation compounds to unlock neuron repair in optic neuropathies (NAION, glaucoma) and several other neuronal diseases. Neurology, glaucoma, NAION, neuroprotection, Neurodegenerative disease, ALS, R&D, and Motoneuron Disease | 2 | 3 |
 | One Biosciences Focused on generating precision medicines by leveraging the power of single-cell technologies One Biosciences leverages the power of single-cell analysis to unlock a new wave of targets and precision medicines for a broad range of difficult-to-treat conditions. One Biosciences is an integrated discovery engine combining a multi-disciplinary team with in-house computational capabilities. One Biosciences is backed by Institut Curie and Home Biosciences. Type: | 12 | 18 |
 | Seekyo Therapeutics Tumor Activated Therapy: targeting Tumor Micro-Environment functional proteins to induce tumor self-destruction The heterogeneity of cancer cells constitutes a strong limitation for the treatment of solid cancers like pancreas and Breast TNBC. Shifting to a new paradigm, Seekyo, a pre-clinical biotech Co. overpowers this challenge by targeting specific functional proteins selectively produced within the Tumor Micro-Environment (TME). Seekyo’s lead compound SKY01 induces a selective tumor self-destruction: • Efficacy and safety validated in small and large animals (e.g. Dogs). • Unprecedented antitumor efficacy vs. Standards of Care • Efficient in several tumors (Pancreas, Triple Negative Breast Cancer, lung, colorectal...) • Low … Type: | 1 | 6 |
 |  Imescia We develop an innovative subcutaneous formulation for anticancer highly potent API to unlock their full potential. IMESCIA is a preclinical-stage company developing a new formulation for anticancer highly potent APIs to unlock their full potential. Type: | 2 | 2 |
 | AUSTRAL Dx Developing a new device based upon airborne ultrasounds improving diagnosis and follow-up of lung and cardiac diseases. AUSTRAL Dx is a French start-up developing a new imaging technology based upon airborne ultrasounds which will map vibrations originating from the lungs (directly or via vocal fremitus) or the heartbeat and appearing on the surface of the skin with a precision of 1 micron. This new device will accelerate and improve the diagnosis and the follow-up of lung and cardiac diseases. Type: | 4 | 7 |
 | BGene Genetics Believe in Nature, belong to Future BGene aims at developing sustainable and resilient production ways for high value added, biobased molecules. To this end, BGene develops expertise in domains such as molecular biology, microbiology, biochemistry, process engineering and computer sciences. Food and feed, pharma, cosmetics, chemistry, and environment are among the diverse markets that BGene can address thanks to the cutting-edge bioprocesses developed by BGene know-how. Strain engineering, Microorganism chromosome engineering, Synthetic Biology, Molecular Biology, Bioinformatics, Bioprocess, and Enzyme Engineering Type: | 12 | 19 |
 | Pasithea A New Approach to treat Sleep Apnea Pasithea: A New Approach to Sleep Apnea Pasithea introduces a novel and groundbreaking non-invasive adaptive neuromodulation approach to address respiratory disorders. The applied stimulation elicits a response from the autonomic nervous system in the early phases of apnea. Clinical studies have shown that Pasithea's therapy is safe and well-tolerated, and that it can significantly improve respiratory disorders. The therapy is also non-invasive, which means that it does not require surgery or hospitalization. Type: | 1 | 5 |
 | TheraPPI Bioscience Targeting protein interactions for health Founded in 2023, TheraPPI Bioscience is a biotechnology company whose science originates from the CRCL (Centre de Recherche de Cancérologie de Lyon, France). We modify protein interactions to offer treatments where current therapies fail. Our approach represents a paradigm shift in tackling cancer resistance and non-curable rare diseases protein-protein interaction, PPI, small molecule, therapeutics, oncology, and rare disease Type: | 3 | 5 |
 | DiogenX Targeting Beta Cell recovery in Diabetes DiogenX is a preclinical stage biotech company committed to a single mission: to discover and develop innovative biologics as new therapeutics options for millions of Diabetic patients around the world. Our lead program, originating from Dr Patrick Collombat’s laboratory, is based on a new approach targeting beta-cell failure throughout the stimulation of beta-cell functional recovery in diabetes. This novel mode of action will provide a unique solution to rebalance glucose/insulin homeostasis and thus offer clear clinically meaningful benefits. DiogenX is headquartered in Marseille, with labs in Nice (France). Biotechnology and Diabetes Type: | 4 | 18 |
 | PepKon PepKon is a french biotechnology company founded in 2022. The company develops first-in-class peptides for the treatment of incurable or poor prognosis cancers. These drug-candidates come from over a decade of academic research, resulting in seven scientific publications and two patent families Type: | 11 | 8 |
 | Valbiotis Valbiotis is a commercially oriented Research & Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases in response to unmet medical needs. Valbiotis has adopted an innovative approach by developing a new class of health nutrition products designed to reduce the risk of major metabolic and cardiovascular diseases, relying on a multi-target strategy enabled by the use of plant-based terrestrial and marine resources. Created at the beginning of 2014 in La Rochelle, the Company has established three sites in France – Périgny, La Rochelle (17) and Riom (63) – and a subsidiary in Quebec City … Type: | 30 | 52 |
 | Corteria Pharmaceuticals Interceptive therapies for the treatment of heart failure subpopulations Development of transformative therapies for the treatment of worsening and acute decompensated heart failure | 2 | 15 |
 | AFYREN Biotech company producing biobased organic acids and derivatives via non-food biomass fermentation 🌿 AFYREN is a pioneering biotech company, developing innovative solutions for the production of high value-added biobased compounds. Our purpose is to “enable low-carbon, circular industry by providing biobased solutions built with our partners to benefit the environment”. Our Technology is based on a biomimetic fermentation process patented worldwide through 10 patent families 🔬 Our production model: AFYREN NEOXY, AFYREN’s first plant is a unique, low-carbon, zero-waste biorefinery that produces 7 100% biobased acids. It is located in Carling Saint-Avold (Grand-Est region, France) a strategic location set in … Type: | 88 | 118 |
 | Laboratoire PediAct A new look at the health of the whole family. By distributing avant-garde and carefully selected family health products, the Pediact laboratory is positioned as a key player in the health and well-being of the whole family. | 0 | 24 |
 | VG2D Pharma A better health accessible to all patients Serious diseases and their impact on patients is what fuels our innovative approach to solving patients' unmet needs. We are leading a new way to treating cystic fibrosis and other disease in need of new solutions. Cystic Fibrosis, Bone Diseases, and Inflammatory Diseases Type: | 10 | 1 |
 | Saxol Neuroprotecting Patient's Future Saxol, newborn company develops innovative compounds able to fight and/or to prevent peripheral neuropathies, including Diabetes peripheral neuropathies, Immuno and Chemotherapy-Induced Peripheral Neuropathies (CIPN). Based on IAB research on Carbazole structure (Lafanechère Team) and with the support of Linksium, we plan to bring to patients, new neuroprotective drugs to answers current Unmet Medical needs CARBA1, our lead compound has neuroprotective activity through a mechanism of regulation and reactivation of energy production at the cellular level. We plan first to develop Carba1 for CIPN Unmet Medical Need and to enlarge after to Diabetes Peripheral Neuropathy DPN and other … Type: | 4 | 2 |
 | QUALIPLANTE Your best partner in plant health testing Qualiplante is a French start-up specialized in the development, the production and the commercialisation of innovative molecular diagnostic tools for the detection of plant diseases. Find the best tool for your plant health testing! Qualiplante offers to plant certification laboratories and all actors of agro-food industry, rapid and easy-to-use all-inclusive molecular kits that permit to detect, in a reliable and sensitive way, pathogens on crops. Validated by worldwide scientific experts, they include all the tools to perform a molecular analysis (ready-to-use master mix, positive and negative controls, analysis protocol). Thanks to the new … Type: | 0 | 1 |
 | Wespran Shaping the future of green biotech Wespran is a French climate deeptech startup specializing in synthetic biology and proteins. It is developing a turnkey biomimetic technology to upcycle industrial CO2 emissions into valuable products, starting with green methanol. At the forefront of biochemistry, physics, and bioinformatics, Wespran's clean biotechnology, FREED (Free Reactions using Enzymatic Electrocatalysis for Decarbonization), harnesses engineered enzymes. This innovative solution offers decarbonization as a service. By leveraging nature's power, Wespran helps industries reduce their carbon footprint while generating substantial profit. Target sectors include refineries, steel plants, chemical manufacturers, incinerators, cement factories, and thermal power plants. With a … Type: | 1 | 2 |
 | Cyprio Created in 2017, Cyprio is founded on ten years of research at the prestigious French institute for higher education in science and engineering, Ecole Supérieure de Physique et Chimie Industrielles de la ville de Paris (ESPCI Paris), with a strong expertise in the field of 3D cell culture, liver biology and drug development. This makes Cyprio the holder of a unique technology for fabrication of alginate liquid-core capsules containing 3D cellular models physiologically more relevant than traditional monolayer cell culture and compatible with high throughput screening applications. Our first product "HepatoPearl" has been validated as a beneficial in vitro liver … Type: | 3 | 2 |
 | SYNAXYS Accelerate drug development for neurological diseases SYNAXYS is French biotech specialized in the characterization of the response of the nervous system for nutraceutic, pharmaceutic and veterinary applications. We offer a complete range of R&D services to support drug development, from defining the dose effects in a human model, to identify biological targets and action mechanism, acute and chronic toxicity, or comparison to established treatments. Our field of application: - Drug positioning - Therapeutic evaluation in a diease model - Neuro-oncology - Data generation for IA modeling Neuro-engineering, Neuronal diseases modeling, Neuro-oncology, Autism, Alzheimer disease, and Glioblastoma Type: | 2 | 2 |
 | CARLA Biotherapeutics First In Class Adoptive Cell Therapies to Cure Patients Carla Biotherapeutics is a Biotech company developing first-in-class adoptive cell therapies tailored to treat diseases with high unmet medical need with a first focus on aggressive life-threatening cancer. Carla Biotherapeutics is founded by a team of seasoned clinicians, cell therapy scientists and biotech professional in Besançon, France with access to a world-class and unique cell-therapy platform. Carla Biotherapeutics’ ambition is to build and develop a pipeline of immunotherapies based on a fully integrated cell therapy platform to discover ena develop adoptive cell therapies tailored to each indication. Type: | 11 | 2 |
 | Cline Research When patients met clinical research. Cline Research is a start-up in clinical research, incubated at IPEPS at the ICM, whose mission is to open clinical research to patients and doctors to make clinical trials accessible and accelerate new therapies on the market. We are developing the cline platform to accelerate recruitment on clinical trials. Cline is available for patients, investigative doctors and directors, and clinical trial promoters. Clinical Research, Clinical Trials, and Patient Course Type: | 6 | 2 |
 | SPIMA Therapeutics Unlocking New Immunotherapy Paths with Smart Peptides SPIMA Therapeutics emerges as a spin-off from the University of Montpellier, France, uniting experts in cutting-edge peptide chemistry and inflammation biology. SPIMA focuses on developing innovative peptide-based immunotherapies for challenging targets, particularly protein-protein interactions. Our lead program is a Stapled Peptide targeting the Myddosome complex. This innovative approach holds immense promise for revolutionizing treatments in inflammatory and oncological diseases, offering hope where it's needed most. SPIMA Therapeutics is part of the nexus of Landmark Bioventures. Join us in shaping the future of medicine, where discovery meets dedication. Immunothery Type: | 1 | 4 |
 | ALPHANOSOS OneHealth/AI DeepTech discovering patentable mixes of natural ingredients preserving health and optimizing bioprecesses Alphanosos, a Green One-Health DeepTech company, uses its own Artificial Intelligence algorithms to discover, develop and market active ingredients and products based on blends of extracts from non-pharmaceutical ingredients, in particular edible plants. These active mixtures, some of which are already patented in 15 countries for their antimicrobial activities, are intended for the animal hygiene, dermocosmetics, food preservation and cosmetics sectors, bioprocess optimization and in the longer term, for functional foods and disease treatments. The company began its Research and Development (R&D) activities in mid-2015 and is … Type: | 4 | 4 |
 | MRGM : Maladies Rares Génétique et métabolisme La recherche du MRGM vise à décrypter les mécanismes moléculaires à l'origine de la physiopathologie des maladies rares. MRGM aims to decipher the molecular mechanisms laying at the root of the physiopathology of rare diseases and make our findings worth for patients | 1 | 5 |
 | Averoa Medicines for people with renal diseases. Averoa is a biopharmaceutical company bringing medicines to people with renal disease. | 4 | 5 |
 | INNOVHEM Innovative science to improve the health of patients To adress the unmet need to dispose of relevant tools to value the efficacy of treatments for red blood cell disorders, INNOVHEM has developed two important and unique innovations :a simple and accurate method to quantify fetal hemoglobin in each red blood cell and a specific new method to measure intravascular hemolysis. Together with several generic biological assays, INNOVHEM offers a comprehensive and innovative platform that supports the development of new treatments for red blod cell pathologies, from preclinical to phase IV evaluation. Type: | 14 | 5 |
 | DNA Gensee Expert in plant genetics guaranteeing traceability and authenticity. DNA Gensee is a biotechnology laboratory offering to identify the plant species present in raw materials, ingredients and finished products from the vegetable DNA they contain. The genetic analyzes carried out making it possible to guarantee botanical, even geographical, authenticity, and to ensure the traceability, safety and quality of the natural extracts used. DNA GENSEE uses innovative molecular biology tools making it possible to blind analyzes and on highly processed products thanks to the unique genetic signature of each plant. At the heart of a technical, scientific and botanical environment, DNA Gensee … Type: | 8 | 4 |
 | Vibiosphen From Microbes to One Health. Taylor made R&D to tackle infectious diseases. Vibiosphen is a SME healthcare biotechnology in infectious diseases founded in 2014. Given the important and interdependent human, animal, and environmental dimensions of antimicrobial resistance, the One Health concept promotes a global effort to achieve the best health for people, animals, and the environment. In this context, Vibiosphen takes part of the efforts that are underway to develop new anti-infective therapies, to rejuvenate the antibiotic pipeline, develop novel antibiotics, and discover innovative therapeutic strategies for priority pathogens. Based on its pluridisciplinary and integrated approaches, Vibiosphen, with more than … Type: | 5 | 6 |
 | Phenocell Phenocell is a research-based biotechnology company specialized in the creation, production, and commercialization of cellular models & bioassays for research and drug discovery. We are your designated partner for open innovation projects, let's reach out! Using the Nobel-prize winning technology of cellular reprogramming, we create foot-print free, feeder-free, hiPSC that are further differentiated into somatic cells and amenable to 3D projects. Large batches of qualified cells can be produced and used in unique phenotypic assays to repurpose existing drugs or discover new compounds. Phenocell has specific expertise in the production of: -human skin cells: sebocytes, melanocytes and keratinocytes -human retinal … Type: | 2 | 9 |
 | TiHive Terahertz-AI Vision. Terahertz-AI Vision company, disrupting industrial process and quality monitoring for a more sustainable and efficient industry. We are an imaging and sensing company providing Terahertz and Artificial Intelligence solutions for industrial quality and process control, sensing, and communications. We are proud to serve customers around the world, with passion and determination to help industries produce the best quality products while getting the most out of the raw materials. We have developed state of the art in-line imaging and sensing systems based on mmwaves and terahertz see-through nanotechnology allied to deep learning that analyse within materials and objects at … Type: | 19 | 10 |
 | Vaxinano Developing life-changing vaccines and immunotherapies Vaxinano is a clinical-stage biotechnology company, developing a new generation of nasally administered vaccines that are more efficient and faster to deploy to combat infectious diseases and new pandemics. The vaccine is based on STELLAR-NP nanoparticles that confer highly stable, adjuvant-free solution for an effective and long-lasting response tot protect against the most difficult pathogens, such as parasites, viruses or bacteria... Biotechnology, Nanotechnology, Vaccine, Animal Health, and Human Health Type: | 14 | 13 |
 | Loop Dee Science Tests you can trust ! Making molecular biology faster and more accessible! Founded in 2017 and based in Caen in Normandy, Loop Dee Science is a DNA expert start-up that makes molecular biology diagnostics more accessible to as many users as possible. Our expertise is based on the use of amplification technology and the creation of tools to automate these tests. We develop and manufacture rapid, reliable and simple genetic analysis kits for use in the field to detect pathogen DNA and RNA. Biologie moléculaire, Kits d'analyses terrain, Kits vétérinaire, Recherche et développement, and PCR Type: | 8 | 13 |
 | Skinosive Innovation in Skin Health Skinosive is a science-driven dermo-cosmetics biotechnology company developing a technology platform in skin photoprotection. Skinosive’s technology enables long-acting skin UV protections and effective sunscreens that prevent chemicals from being absorbed into the skin and the bloodstream. This innovation aims to reduce drastically cancer and skin damages due to the sun exposure. The company is located in Paris and in Marseille. Skinosive Headquarter : 12-14 rue Jean Antoine de Baïf 75013 Paris Skinosive Lab : 60 avenue André Roussin 13016 Marseille | 2 | 12 |
 | ALCEDIAG Biomarker-based diagnostics for Mental Health Biomarker-based diagnostics for Mental Health ALCEDIAG is a personalized medicine company specializing in the development of biological signatures aimed to serve as the basis of diagnostics tools, with a primary focus on mental health. These biomarkers are based on the analysis of RNA editing, an epigenetic mechanism altering the nature and conformation of RNA. RNA editing may lead to the production of altered forms of proteins or modify the regulation of gene expression. RNA editing can be modified in the case of certain diseases, or as a consequence of a medical treatment. ALCEDIAG blood biomarkers … Type: | 17 | 15 |
 | Minos Biosciences What You See Is What You Seq - Revolutionary cell analysis solution for fundamental, translational & pharma/biotech R&D Minos Biosciences is on the path to bridge molecular and cell biology in a manner never achieved before that will, in turn, allow scientists to uncover the full picture of cell diversity and dynamics. By combining multi-omics analysis with phenotypic analysis at cell resolution and at high throughput, Minos’ solution provides a new paradigm in cell analysis that will open up new frontiers in life science research, precision medicine and diagnostics. Type: | 11 | 16 |
 | Eurosafe CRO Eurosafe is a sub-contract research company (CRO) certified good laboratory practices (BPL), specialized in human and veterinary pharmaceuticals, cosmetic products (ingredients and finished products), food supplements and medical devices. Depending on your products, a single contact, surrounded by scientists and regulatory experts supports you to define and carry out regulatory procedures, carry out the admit tests (absorption, distribution, metabolism and elimination), safety, tolerance or efficiency required to market your products. Eurosafe is a single CRO with multiple skills, organized around 3 complementary centers: - In vitro tests - Volunteer tests - Toxicological and regulatory expertise Eurosafe is approved for the … Type: | 6 | 17 |
 | PhinC Development 15 years of Quantitative Pharmacology Solutions applied to the development of drug candidates. PhinC Development is the PK Modeling & Simulation partner for small to medium sized pharmaceutical or biotech companies, who need to move forward in early drug research. Based on Model-Informed Drug Development, PhinC helps you to increase the confidence in decision making and reduces cycle time of your development. Our mission consists in developing the best models to take advantage of all the research data at every phase (in vitro, in vivo animal and human) and carry out robust simulations and predictions requested and recommended by the … Type: | 8 | 17 |
 | Laboratoires ERIGER Laboratoires ERIGER was acquired by Groupe Berkem. To find out more, click on the link “Visit the website”. 📍Tours 🌱New encapsulation technology through chlorophyll 🌿 Vegan, natural & sustainable 💪High concentration, protection, penetration, stability of active molecules. Show more Show less protection, Tailor-made, cosmetic, and pharmacy Type: | 11 | 15 |
 | Antofénol Our vision: get the best of the plant, without using conventional chemical solvents. Our know -how: - Simultaneously exploit 4 proven eco-extraction technologies. - Provide solutions for the development of your ingredients in order to enrich your range of active biomolecules (polyphenols, flavonoids, alkaloids) Our objective: to propose eco -responsible solutions to allow you to meet the ecological and economic challenges to come. Vacuum distillation, plant eco-extraction, r & amp; D, objectified ingredients, microwaves, ultra-sons, atomization, freeze-down, grinding, natural extracts, active ingredient, 100% natural active, eco-responsible, polyphenols, essential oils, cosmetics, perfumery, nutracheme, and food food Type: | 15 | 20 |
 | ANTABIO Developing Tomorrow's Antibacterials Antabio is a privately-held clinical-stage biopharmaceutical company developing novel and highly differentiated antibacterial treatments for drug-resistant infections due to CDC and WHO critical priority pathogens. Please visit www.antabio.com and follow us on Twitter @antabio Antibacterial drug discovery, Drug development, and Antibiotic Adjuvant Type: | 22 | 21 |
 | Idylle The tech transfer platform for research tools in life sciences Idylle is the tech transfer platform for life science tools. We transform researchers innovations into products to help scientists try the just-published research tools. They are all made by researchers for researchers. WE ARE THE TOOL PARTNER OF THE RESEARCHERS We transform their technologies into robust and reliable research products. The life science tools we co-develop, produce and deliver are all designed by researchers. They are meant for communities of academic and private researchers. They are produced on demand. They are fully assembled in our laboratories and made in France. … Type: | 4 | 28 |
 | Physics for Medicine Paris Inserm, ESPCI Paris-PSL, CNRS - Invent the future of biomedical technologies Physics for Medicine Paris is a French academic research institute dedicated to develop non-invasive technologies for medical imaging and therapy based on innovative concepts of wave physics. Type: | 5 | 26 |
 | AELIS FARMA A clinical stage biotech company opening a new frontier in pharmacology Aelis Farma is a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases. Aelis Farma is developing a new class of drugs: Signaling Specific inhibitors of the CB1 receptor (CB1-SSi) of the endocannabinoid system that provide access to several therapeutic areas without available treatments. These unique drug candidates, by reproducing a recently discovered natural defense mechanism of the brain , appear to be able to treat various brain pathologies without disrupting normal behavior. A first in pharmacology. Two initial drug candidates are already in clinical trials … Type: | 6 | 31 |
 | Epigene Labs augmented intelligence for precision oncology research and drug development Epigene Labs is creating the intelligence-augmenting solution for precision oncology research and drug development. Designed by cancer scientists for cancer scientists, the company's mCUBE platform accelerates data-driven drug discovery, biomarker identification, and patient selection -- to bring better treatments to patients faster. Based in Paris and Boston, Epigene Labs was initially incubated at the Harvard Innovation Labs and launched in France with the support of prominent European investors. Epigene Labs has partnerships with world-class cancer research institutes and biopharmaceutical companies. Type: | 15 | 34 |
 | Astraveus We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. biotech, medtech, cell therapy, gene therapy, CAR-T, MSC, iPS, ATMP, Tissue Engineering, cell based therapies, biotherapies, RMAT, and Manufacturing Tags: FrenchTech2030 Type: | 15 | 57 |
 | Micropep Technologies Micropep is an innovative plant biotechnology company developing the next generation of biological crop protection solutions based on the incredible potential of micropeptides; short natural peptide molecules that target and regulate plant genes and proteins. Type: | 26 | 64 |
 | Qubit Pharmaceuticals Anything is Druggable - with Quantum Accuracy Qubit Pharmaceuticals brings unparalleled accuracy and precision to drug discovery and design, using quantum physics to develop life-changing treatments for major diseases. We leverage our technologies and expertise to advance 7 fully owned drug discovery programs focusing on cancer resistance and escapement, a growing concern in aging populations, and chronic inflammatory diseases. We also co-develop programs with academia and pharmaceutical partners. Our proprietary ATLAS drug discovery platform unites our technologies based on 30 years of research from renowned scientists and founders, Louis Lagardère (Sorbonne University and CNRS), Matthieu Montes (CNAM), Jean-Philip Piquemal (Sorbonne … Tags: FrenchTech2030 Type: | 60 | 68 |
 | ID SOLUTIONS ID SOLUTIONS offers comprehensive Molecular Typing Assays using DigitalPCR for Oncology Diagnostics Our mission To provide innovative, reliable and standardized tools for oncology diagnostic. Research on circulating DNA from liquid biopsy, tumor DNA from solid biopsies. Our team is of molecular biology specialists with more than 20 years of expertise in nucleic acid extraction, molecular biology and oncology. Our proposals To offer a complete molecular typing solution, standardized operating procedures and custom development to improve diagnosis in oncology. biologie moléculaire, diagnostic oncologique, ADN circulant, biopsie liquide, PCR, Digital PCR, Multiplexing, Covid-19, and SARS-CoV-2 | 6 | 81 |
 | TISSIUM Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully … Tags: FrenchTech120 Type: | 17 | 129 |
 | Grand Challenges Canada Bold Ideas with Big Impact Grand Challenges Canada is dedicated to supporting Bold Ideas with Big Impact®. Funded by the Government of Canada and other partners, Grand Challenges Canada funds innovators in low- and middle-income countries and Canada. The bold ideas Grand Challenges Canada supports integrate science and technology, social and business innovation – known as Integrated Innovation®. One of the largest impact-first investors in Canada, and with a feminist investment approach, Grand Challenges Canada has supported a pipeline of over 1400 innovations in more than 102 countries. Grand Challenges Canada estimates that these innovations have the potential to save … Type: | 15 | 132 |
 | Kern Pharma Our mission for +25 years is to take care of the health of people with an eye on the future and innovation. Kern Pharma is a Privately Held Pharmaceutical Company That Belongs to the Induken Group and Has ITS Commercial Activities in The Ethical and Hospital Field With Both Generic and Branded Products. FURTERMORE IS A RELIABLE PARTER FOR CONTRACT MANUFACTURING ACTIVITIES FOR IMPACT PLAYERS OF THE PHARMACETICAL MARKET. Kern Pharma is the pharmaceutical company of the Indukern group. It bases its activity around two strategic business axes: - The development, manufacture and marketing of pharmaceutical products (mainly generic, but … Type: | 4 | 857 |
 | The American Academy of Anti-Aging Medicine (A4M) Redefining Medicine A4M is dedicated to the advancement of tools, technology, and transformations in healthcare that can detect, prevent, and treat age-related diseases. A4M further promotes the research of practices and protocols that have the potential to optimize the human aging process. The organization is also dedicated to educating healthcare professionals and practitioners, scientists, and members of the public on biomedical sciences, breaking technologies, and issues related to the anti-aging industry. Our mission is to redefine modern medicine by providing clinicians with the education and resources needed to provide whole person care that optimizes healthspan and vitality for patients worldwide. … Type: | 2 | 72 |
 | TransCelerate BioPharma Inc. Accelerating answers with a mission for collaboration across the biopharmaceutical R&D community. TransCelerate BioPharma Inc. was launched in 2012 as a non-profit organization to improve the health of people around the world by accelerating and enhancing the research and development of innovative new therapies. Our mission is to collaborate across the global biopharmaceutical research and development community to identify, prioritize, design and facilitate implementation of solutions designed to drive the efficient, effective and high-quality delivery of new medicines. Our membership is made up of 20 of the world’s most innovative and successful biopharmaceutical organizations who provide their best talent to … Type: | 17 | 78 |
 | Avantium Avantium develops and commercialises innovative chemistry technologies in order to produce chemicals and materials based on renewable feedstock instead of fossil resources. Our two lead products are FDCA and plantMEGTM. Together, they enable the production of the novel plastic PEF: 100% plant-based, recyclable and degradable with superior performance. Avantium also provides advanced catalysis products and services to organisations who desire to gain efficiency in their processes. high throughput experimentation, contract research, catalysis, green plastics, renewable chemistry, biorefining, and renewable polyesters Type: | 17 | 341 |
 | CELLINK Create the future of health CELLINK is proud to be part of BICO. BICO is a lab automation partner and provider of selected workflows to pharma and biotech. With 48,000+ instruments installed in over 65 countries, BICO products, software, and solutions are found in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, and have been cited in over 11,900 publications. Operating through three business areas – Lab Automation, Life Science Solutions, and Bioprinting – BICO strives towards the vision to enable and automate the life science lab of the future. BICO is listed on Mid-Cap, Nasdaq Stockholm … Type: | 20 | 98 |
 | UNC Lineberger Comprehensive Cancer Center North Carolina's only public comprehensive cancer center, serving patients at the N.C. Cancer Hospital. One of the leading cancer centers in the nation, UNC Lineberger Comprehensive Cancer Center is located in Chapel Hill, North Carolina. UNC Lineberger is one of only 57 National Cancer Institute-designated Comprehensive Cancer Centers and was rated as exceptional - the highest category - following its most recent NCI review. The center brings together some of the most exceptional physicians and scientists in the country to focus on advancing the prevention, early detection and treatment of cancer. With research that spans the spectrum from the laboratory … Type: | 11 | 480 |
 | Neurocern Connecting clinical and financial data, an artificial intelligence engine that transforms data into actionable insights Neurocern is a minority female physician-founded, and veteran-owned AI and neuroinformatics company. Neurocern’s AI platform ingests data from previously siloed sources — including electronic health records, prescription data, insurance claims data, and more — to uncover insights that drive health outcomes, enterprise performance, and financial ROI for health systems, insurers, and life sciences companies. Predictive Analytics, Dementia, Clinical Decision Support, Alzheimer's Disease, Parkinson's Disease, informatics, Artificial Intelligence, Prescriptive Analytics, and Stroke Type: | 8 | 1 |
 | Biofourmis Revolutionizing the Delivery of Healthcare. Biofourmis brings the right care to every person, no matter where they are. The company’s AI-driven solution collects and analyzes over 120 biomarkers in real time and identifies shifts that require proactive interventions. This vital innovation enables Biofourmis to offer people everywhere connected access to hospital-level services, virtual provider networks for remote care, and life-changing clinical trials—all without leaving their homes. Trusted by leading health systems, payers, biopharma companies and patients alike, Biofourmis’ connected platform improves patient outcomes, prevents hospitalization readmissions, accelerates drug development, and closes critical gaps in care—with the goal of making science … Type: | 34 | 260 |
 | Genetic Literacy Project Science Not Ideology The Genetic Literacy Project fosters dialogue about the scientific, social and ethical implications of genetic technologies, human and agricultural. It respects the uncertainties inherent in science but is grounded in the conviction that genomic research is an engine of innovation and job creation. The GLP is designed to help journalists, scientists and policymakers navigate the increasingly politicized arena of biotechnology, genetic engineering, CRISPR gene editing, medical genomics and related sciences, such as nanotechnology and epigenetics. Type: | 0 | 13 |
 | PharmaVie Our good. Your well-being. Independent independent independent Distributor Brand products Isomed our brand of generic to the brand Commercial dynamism Sign marketing Price policy Training Nutritherapy The brand is an important visual identification for the pharmacist who now must group himself with a view to the economic changes in the pharmacy (OTC, drop in margins, CAP etc ...) Pharmaceutical industry, drugstore, and pharmacy | 12 | 115 |
 | BioNeed - Conseils stratégique et appui opérationnel Secteur Biotechnologie-santé Your teammate in marketing strategy, business design & amp; Activity management - Deeptech Health innovations sector www.bioneed.fr Operational support for managers of biotechnology/health companies. Bioneed offers consulting services, tools and field support to deploy your business project, boost your performance and strengthen your marketing functions & amp; commercial. The services are mainly focused on innovation marketing, commercial strategy and activity management. For whom? Bioneed is mainly aimed at SMEs at different stages of their development: ante-creation, first development, growth, etc.). How? Operational support in your business and interventions adapted to your needs and your development stage. Punctual mission or on … Type: | 5 | 1 |
 | Union for International Cancer Control (UICC) Uniting the global cancer community to reduce the cancer burden together. The Union for International Cancer Control (UICC) is the largest international cancer membership organisation in the world. It has more than 1,100 organisational members in 170 countries. The organisation is dedicated to taking the lead in convening, capacity building and advocacy initiatives that unite and support the cancer community to reduce the global cancer burden, promote greater equity, and to ensure cancer control continues to be a priority in the world health and development agenda. Through UICC’s UN Economic and Social Council (ECOSOC) status, UICC enjoys formal relationships with … Type: | 15 | 120 |
 | SIFI Since 1935 always committed to improve patients’ quality of vision. SIFI is expanding into international market providing innovative solutions for ocular diseases. Eye Care, Pharmaceutical/Nutraceuticals/Medical Devices, Surgical & Diagnostic Medical Devices., Ophthalmology , Science, Researchers , Research, Vision, Eyes, Surgical, Medical technology, Health, Medicine , Eye health , and Biotech Type: | 2 | 616 |
 | PHAXIAM Therapeutics Creating a global leader in extended phage therapies PHAXIAM is a biopharmaceutical company developing innovative treatments for resistant bacterial infections, which are responsible for many serious infections. The company is building on an innovative approach based on the use of phages, natural bacterial-killing viruses. PHAXIAM is developing a portfolio of phages targeting 3 of the most resistant and dangerous bacteria, which together account for more than two-thirds of resistant hospital-acquired infections: Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. PHAXIAM is listed on the Nasdaq Capital Market in the United States (ticker: PHXM) and on the Euronext regulated market in Paris … Type: | 20 | 85 |
 | Innate Pharma Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need. Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical … Type: | 26 | 196 |
 | BIOGARAN The box that takes care of yourself. French drug laboratory 🇫🇷 Biogaran was founded in 1996, to specifically respond to the development of a new market that is still unknown: generic drugs. Offering patients with recognized quality drugs whose patent fell into the public domain then was a new type of know-how that traditional laboratories did not have. Our know-how is available through different ranges: small everyday ailments with the Biogaran Conseil® range, to heavier pathologies with prescription drugs. Whatever pathology, patient health is at the heart of biogaran concerns and the same rigor is brought to the development of … Type: | 10 | 546 |
 | ILYA Pharma Ilya Pharma 🇸🇪🇺🇸 is bringing local-acting immunotherapies to patients Ilya Pharma 🇸🇪🇺🇸 is bringing local-acting immunotherapies to patients ATMP, Gene Therapy, Biologics, Drug development, Clinical trials, GMP, Growth, H2020, Uppsala, IBD, Wound treatment, Scar, Topical, Oral, Research, Science, Immunology, Immunophysiology, microbiology, Applied microbiology, Regulatory excellence, Skin, Diabetes, Cutting edge, and IBD Type: | 8 | 14 |
 | HEXO Corp HEXO Corp est une entreprise primée de biens de grande consommation qui conçoit et distribue des produits de cannabis destinés au marché mondial, produits récompensés par plusieurs prix. Dans le cadre de sa stratégie commerciale en étoile, HEXO Corp s’associe à des entreprises du Fortune 500, leur apportant la valeur de sa marque, sa technologie d’isolement des cannabinoïdes, son infrastructure sous licence et son expertise en réglementation, tirant parti à son tour de leurs réseaux et capacités de distribution. L’une des plus importantes entreprises autorisées de production de cannabis au Canada, HEXO déploie ses activités sur 2 000 000 pi2d’installations … Type: | 0 | 240 |
 | HepatoChem Reinventing Chemistry for Life Sciences The leading innovator and manufacturer of photoreactors, metabolites and LEDs since 2008 Metabolite synthesis, photochemistry, research instrument, and photoreactor Type: | 0 | 8 |
 | Butler Scientifics #10YearsExploringData with AutoDiscovery, an intelligent automated exploratory data analysis software. Butler Scientifics developes AutoDiscovery, an automated smart exploratory data analysis software that helps biomedical researchers at unveiling clinically relevant associations hidden in their datasets. Butler Scientifics is a privately held company headquartered in Barcelona, Spain. The founder, Ray G. Butler and his partner Luis García, each have over 10 years experience in Life Sciences. Ray G. Butler was formerly Software R&D Manager and then progressed into Product Development in terms of Marketing. Luis García has extensive Business Development and Sales Management experience. Software, Research, Exploratory Data Analysis, Life Sciences, Neurosciences, … Type: | 5 | 10 |
 | Dynamic42 GmbH Develop human organ models with true physiological complexity We are specialized in the production and development of human, immunocompetent Organ-on-Chip technology for in vitro disease and infection modelling. Organ-on-Chip, Human Cell Biology, Infection, Infectious disease, Toxicity profiling, Immune Cell Interactions, Inflammatory Diseases, Antibody recycling, and Uptake / Transport studies Type: | 1 | 22 |
 | Qureight Data curation to accelerate drug development Qureight is a clinical data analytics company based in Cambridge UK. Working with healthcare institutions, technology companies and the pharmaceutical industry our platform allows the realisation of new endpoints in clinical data. Show more Show less Type: | 8 | 34 |
 | Occuity Occuity is developing novel optical monitoring & diagnostic devices. Occuity's mission is to improve the lives of hundreds of millions of people by developing painless, contact-free screening & monitoring solutions for health conditions such as #diabetes, #myopia, #glaucoma and #Alzheimer's Disease. Occuity is a UK-based medical technology company specialising in the research, design, and production of handheld non-contacting optical instruments for use in healthcare, diagnostics, and monitoring. Occuity’s scanning technology uses light to obtain precise measurements of different structures within the eye. This will enable direct measurements of the eye for optometrists and ophthalmologists but also other more general health … Type: | 3 | 40 |
 | Cytochroma Accelerating global drug development Cytochroma predict how drugs will react in a global population in health or disease. Our unique, ethnically diverse library of iPSC and automated cell culture generates robust, reliable, mature hepatocytes for toxicity testing. We are supporting life science companies, de-risking safe compounds prior to clinical testing, making new drug development faster, safer and more efficient. toxicity testing, liver specialists, hepatocyte testing, disease models, high throughput, high content screening, iPSC, automated manufacture, machine learning, artificial intelligence, predictive testing, and pre clinical testing Type: | 2 | 4 |
 | Causaly Unlock R&D productivity with the most complete AI platform for life sciences. Our mission at Causaly is to redefine the boundaries of human discovery by harnessing transformative AI technologies. Founded in 2018, Causaly’s unique AI platform is a powerful catalyst for the modern Life Science research organization, reshaping how data is found, analyzed and applied in critical decision-making processes in drug discovery and development. Supporting a broad range of complex knowledge workflows, our platform accelerates the journey from bench research and laboratory insights to the launch of life-changing therapies. Artificial Intelligence, Natural Language Understanding, Knowledge graphs, Pharma, and Life Sciences Type: | 6 | 126 |
 | CRISPR Therapeutics Since its inception over a decade ago, CRISPR Therapeutics has evolved from a research-stage company advancing gene editing programs into a leader that celebrated the historic approval of the first-ever CRISPR-based therapy. The Company has a diverse portfolio of product candidates across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, cardiovascular, autoimmune, and rare diseases. In 2018, CRISPR Therapeutics advanced the first-ever CRISPR/Cas9 gene-edited therapy into the clinic to investigate the treatment of sickle cell disease and transfusion-dependent beta thalassemia. Beginning in late 2023, CASGEVY® (exagamglogene autotemcel [exa-cel]) was approved in several countries to treat eligible patients … Type: | 12 | 442 |
 | BIOTECAL Biotal is a biotechnology company that is looking for, develops and values innovative marine biomolecules. The unique expertise and know-how of biiotal allow the identification, characterization and marketing of molecules with very high potential for various sectors such as cosmetics, pharmaceutics or neutraceutics. Blue biotechnology, microbiology, biodiversity, and production of polymers Type: | 0 | 3 |
Startup